Literature DB >> 15880066

Augmented Induction of CD4+CD25+ Treg using monoclonal antibodies to CD200R.

Reginald M Gorczynski1, Lydia Lee, Ivo Boudakov.   

Abstract

BACKGROUND: CD200 is a transmembrane protein delivering immunoregulatory signals after engagement of CD200R. A family of CD200Rs exist (CD200R1-4) with different tissue expression and functional activity. In the presence of anti-CD200R2/3 monoclonal antibodies (mAbs), bone-marrow cells cultured in the presence of (interleukin [IL]-4+granulocyte-macrophage colony-stimulating factor) differentiate into dendritic cells (DCs), which induce CD4+CD25+ Treg. The effect of these mAbs on Treg induced in anti-CD3 activated thymocyte cultures is unknown.
METHODS: BL/6 bone-marrow cells were cultured with GMC-SF and IL-4 in the presence/absence of anti-CD200Rs to generate DCs that induced Treg in C3H lymph-node T cells. Treg were also induced in anti-CD3/CD28-activated C3H thymocytes. Treg activity was assayed by (1) suppression of mixed leukocyte culture (MLC) in cultures using C3H stimulator spleen cells and BL/6 stimulator cells, and (2) by expression of the transcription factor, Foxp3.
RESULTS: Addition of anti-CD200R2/3 mAbs (but not anti-CD200R1) to bone-marrow cultures led to generation of DCs that induced a CD4+CD25+ (Treg) population inhibiting MLCs (C3H cells stimulated with C57BL/6 cells) in a cytotoxic T-lymphocyte-associated antigen (CTLA)-4 and transforming growth factor (TGF)-beta-dependent manner. Anti-CD200R2, but not anti-R1/R3, augmented induction of Foxp3-expressing Treg from anti-CD3/CD28 activated thymocytes. Suppression in MLCs by anti-CD200R1 mAbs was dependent on IL-10 and TGF-beta.
CONCLUSIONS: Unlike anti-CD200R1, anti-CD200R2 both promotes development of DCs with capacity to induce Treg and directly augments thymocyte production of Treg.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15880066

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  21 in total

Review 1.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

2.  T regulatory cell suppression of colitis: the role of TGF-beta.

Authors:  R Duchmann; M Zeitz
Journal:  Gut       Date:  2006-05       Impact factor: 23.059

3.  Ibrutinib treatment improves T cell number and function in CLL patients.

Authors:  Meixiao Long; Kyle Beckwith; Priscilla Do; Bethany L Mundy; Amber Gordon; Amy M Lehman; Kami J Maddocks; Carolyn Cheney; Jeffrey A Jones; Joseph M Flynn; Leslie A Andritsos; Farrukh Awan; Joseph A Fraietta; Carl H June; Marcela V Maus; Jennifer A Woyach; Michael A Caligiuri; Amy J Johnson; Natarajan Muthusamy; John C Byrd
Journal:  J Clin Invest       Date:  2017-07-17       Impact factor: 14.808

Review 4.  Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?

Authors:  Celalettin Ustun; Jeffrey S Miller; David H Munn; Daniel J Weisdorf; Bruce R Blazar
Journal:  Blood       Date:  2011-08-31       Impact factor: 22.113

5.  Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.

Authors:  Zhengming Xiong; Elisabet Ampudia-Mesias; Rob Shaver; Craig M Horbinski; Christopher L Moertel; Michael R Olin
Journal:  Immunotherapy       Date:  2016-09       Impact factor: 4.196

Review 6.  Checkpoint Proteins in Pediatric Brain and Extracranial Solid Tumors: Opportunities for Immunotherapy.

Authors:  Eric K Ring; James M Markert; G Yancey Gillespie; Gregory K Friedman
Journal:  Clin Cancer Res       Date:  2016-11-10       Impact factor: 12.531

Review 7.  Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal?

Authors:  Konstantinos Minas; Janet Liversidge
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

8.  Merkel cell carcinoma expresses the immunoregulatory ligand CD200 and induces immunosuppressive macrophages and regulatory T cells.

Authors:  Maria Rita Gaiser; Cleo-Aron Weis; Timo Gaiser; Hong Jiang; Kristina Buder-Bakhaya; Esther Herpel; Arne Warth; Ying Xiao; Lingling Miao; Isaac Brownell
Journal:  Oncoimmunology       Date:  2018-02-08       Impact factor: 8.110

Review 9.  The molecular characterization and clinical management of multiple myeloma in the post-genome era.

Authors:  Y Zhou; B Barlogie; J D Shaughnessy
Journal:  Leukemia       Date:  2009-08-06       Impact factor: 11.528

10.  Decreased CD200R expression on monocyte-derived macrophages correlates with Th17/Treg imbalance and disease activity in rheumatoid arthritis patients.

Authors:  Song Gao; Bing Hao; Xu Feng Yang; Wei Qian Chen
Journal:  Inflamm Res       Date:  2014-02-05       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.